LU81598A1 - Nouveaux derives d'imidazole,leur procede de production et composition pharmaceutique les contenant - Google Patents

Nouveaux derives d'imidazole,leur procede de production et composition pharmaceutique les contenant Download PDF

Info

Publication number
LU81598A1
LU81598A1 LU81598A LU81598A LU81598A1 LU 81598 A1 LU81598 A1 LU 81598A1 LU 81598 A LU81598 A LU 81598A LU 81598 A LU81598 A LU 81598A LU 81598 A1 LU81598 A1 LU 81598A1
Authority
LU
Luxembourg
Prior art keywords
formula
compound
group
radical
imidazole
Prior art date
Application number
LU81598A
Other languages
English (en)
French (fr)
Inventor
R Dickinson
P Cross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU81598A1 publication Critical patent/LU81598A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
LU81598A 1978-08-15 1979-08-13 Nouveaux derives d'imidazole,leur procede de production et composition pharmaceutique les contenant LU81598A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7833456 1978-08-15
GB7833456 1978-08-15
GB7926146A GB2028317B (en) 1978-08-15 1979-07-26 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors
GB7926146 1979-07-26

Publications (1)

Publication Number Publication Date
LU81598A1 true LU81598A1 (fr) 1981-03-24

Family

ID=26268547

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81598A LU81598A1 (fr) 1978-08-15 1979-08-13 Nouveaux derives d'imidazole,leur procede de production et composition pharmaceutique les contenant

Country Status (8)

Country Link
US (1) US4230714A (de)
AU (1) AU4989579A (de)
BE (1) BE878230A (de)
DE (1) DE2932967A1 (de)
FR (1) FR2433525A1 (de)
GB (1) GB2028317B (de)
LU (1) LU81598A1 (de)
NL (1) NL7906148A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR71915B (de) * 1979-11-27 1983-08-16 Pfizer
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
DE3333314A1 (de) * 1983-09-15 1985-03-28 Hoechst Ag, 6230 Frankfurt Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
JPS61110266A (ja) * 1984-11-05 1986-05-28 Omron Tateisi Electronics Co カード発行方法
IL82401A0 (en) * 1986-05-06 1987-11-30 Merrell Dow Pharma Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them
DE3789754T2 (de) * 1986-11-20 1994-12-15 Mitsubishi Chem Ind Die Bildung von Lipid-peroxiden hemmende Zusammenstzung und dafür geeignete Verbindungen.
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4131584A1 (de) * 1991-09-23 1993-03-25 Sandoz Ag Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
CN1040107C (zh) * 1993-01-02 1998-10-07 山道士有限公司 咪唑基甲基吡啶
GB0009037D0 (en) * 2000-04-13 2000-05-31 Novartis Ag Organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH204740A (de) * 1935-07-23 1939-05-15 Chem Ind Basel Verfahren zur Darstellung eines in 2-Stellung substituierten Imidazoldihydrids-(4,5).
FR1479120A (fr) * 1965-05-10 1967-04-28 Ward Blenkinsop & Co Ltd Composés imidazoliques et leur préparation
NL135940C (de) * 1965-05-10
US4058614A (en) * 1973-12-04 1977-11-15 Merck & Co., Inc. Substituted imidazole compounds and therapeutic compositions therewith
DE2418502C3 (de) * 1974-04-11 1980-04-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
GB2028317B (en) 1982-11-10
FR2433525B1 (de) 1981-12-11
NL7906148A (nl) 1980-02-19
US4230714A (en) 1980-10-28
AU4989579A (en) 1980-02-21
FR2433525A1 (fr) 1980-03-14
GB2028317A (en) 1980-03-05
DE2932967A1 (de) 1980-03-20
BE878230A (fr) 1980-02-13

Similar Documents

Publication Publication Date Title
LU82224A1 (fr) Nouveaux 3-(1-imidazolylalkyl)indoles, leur procede de production et composition pharmaceutique les contenant
LU82087A1 (fr) N-benzylimidazoles inhibiteurs selectifs de thromboxannesynthetase,leur procede de production et compositions pharmaceutiques les contenant
LU81985A1 (fr) Nouveaux derives d'imidazole,leur procede de production et composition pharmaceutique les contenant
FR2581993A1 (fr) Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
EP0370901A1 (de) Zentralnervensystem wirksame Chromanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
LU81598A1 (fr) Nouveaux derives d'imidazole,leur procede de production et composition pharmaceutique les contenant
EP0040591A1 (de) Pyridoxin-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
CH645642A5 (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant.
FI84057C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva fluorallylaminderivat.
KR100281867B1 (ko) 3-(비스-치환페닐메틸렌)옥신돌유도체
CA1231950A (fr) Procede d'obtention de nouveaux derives substitues du 2,5-diamino 1,4-diazole et des compositions pharmaceutiques en renfermant
US4699928A (en) Fluoroallylamine derivatives
CH648285A5 (fr) Acides benzoyl-3-nitro-2-phenylacetiques et sels metalliques, amides et esters correspondants utiles notamment comme medicaments anti-inflammatoires, procede et composes pour leur preparation.
FR2521992A1 (fr) Nouveaux composes de pyridine utiles comme medicaments
EP0021924B1 (de) Indol-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende pharmazeutische Zusammensetzungen
CH646138A5 (fr) Amino-2-benzoyl-3-phenylacetamides et leurs homologues cycliques utiles comme medicaments et compositions pharmaceutiques les contenant.
EP0362006A1 (de) Chinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
FR2615511A1 (fr) Derives de benzazepines a action therapeutique
EP0347305B1 (de) [(Aryl-4-piperazinyl-1)-2-ethoxy]-3p-cymole, die ortho-, meta-, para-monosubstituierten oder disubstituierten Derivate, das Verfahren zu deren Herstellung und die als aktives Prinzip diese Verbindungen enthaltenden Arzneimittel
EP0412898A1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
FR2599033A1 (fr) Derives des 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant
FR2692894A1 (fr) Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments.
FR2465724A1 (fr) Nouveaux derives de decahydroquinoleinol, leur procede de preparation ainsi que leurs applications en therapeutique
LU85212A1 (fr) Nouveaux derives de l'acide lysergique,leur preparation et leur utilisation comme medicaments
BE876020A (fr) Derives de la moranoline